Immunotherapy Biomarkers 2016: Overcoming the Barriers
The NCI and the Society for the Immunotherapy of Cancer are co-sponsoring a meeting on Immunotherapy Biomarkers to review the state of the art, discuss current hurdles to further success, and consider recommendations to move the field forward. The main goals are to provide updated information to a wide audience and promote successful immune biomarker research. This one-day event will be divided into four didactic sessions representing the four working groups of the SITC 2015-2016 Immune Biomarkers Task Force. Each session will include presentations by members of one working group followed by a 30-minute panel discussion de...
Source: Videocast - All Events - March 2, 2016 Category: Journals (General) Tags: Upcoming Events Source Type: video
Immunology and Immunotherapy of Hepatocellular Carcinoma
Presented by: Tim F. Greten, M.D., Head, Gastrointestinal Malignancy Section, Thoracic and Gastrointestinal Oncology Branch, Center for Cancer Research, NCI, NIH
Category: NCI CCR Grand Rounds (HHS Only)Aired date: 11/20/2015 (Source: Videocast - All Events)
Source: Videocast - All Events - November 24, 2015 Category: Journals (General) Tags: Past Events Source Type: video
Immunology and Immunotherapy of Hepatocellular Carcinoma
NCI’s Center for Cancer Research (CCR) Grand Rounds Dr. Greten received his medical training at ChristianAlbrechts University in Kiel, Germany. He did an internship in Munich followedby a postdoctoral fellowship at The Johns Hopkins University, Baltimore,Maryland, in the laboratory of Drew Pardoll and Liz Jaffee, where he initiatedhis work in the field of tumor immunology. In 1999 Dr. Greten finished histraining in internal medicine, medical oncology, and gastroenterology atHannover Medical School. He then served as an associate professor in theDepartment of Gastroenterology, Hepatology, and Endocrinology. In February 20...
Source: Videocast - All Events - November 16, 2015 Category: Journals (General) Tags: Upcoming Events Source Type: video
2010-2015: Cancer Immunotherapy's Inflection Point
Presented by: Drew M. Pardoll M.D., Ph.D., Johns Hopkins School of Medicine, The Sidney Kimmel Comprehensive Cancer CenterCategory: NCI CCR Grand Rounds (HHS Only)Aired date: 10/02/2015 (Source: Videocast - All Events)
Source: Videocast - All Events - October 5, 2015 Category: Journals (General) Tags: Past Events Source Type: video
1) Lentivector Gene Therapy for X-linked Severe Combined Immune Deficiency (XSCID) in Older Children, Young Adults with Impaired Immunity 2) A New Approach to Cancer Immunotherapy Targeting Unique Cancer Mutations
Presented by: Harry L. Malech, Chief, Laboratory of Host Defenses and Chief, Genetic Immunotherapy Section, NIAID, NIH and Steven A. Rosenberg, MD, PhD, Chief, Surgery Branch, NCI, NIHCategory: Clinical Center Grand RoundsAired date: 09/30/2015 (Source: Videocast - All Events)
Source: Videocast - All Events - October 1, 2015 Category: Journals (General) Tags: Past Events Source Type: video
2010-2015: Cancer Immunotherapy's Inflection Point
NCI’s Center for Cancer Research (CCR) Grand RoundsDr. Pardoll is an Abeloff Professor of Oncology,Medicine, Pathology and Molecular Biology and Genetics at the Johns HopkinsUniversity, School of Medicine. He isDirector of the Cancer Immunology in the Sidney Kimmel Comprehensive CancerCenter. Dr. Pardoll attended JohnsHopkins University, where he earned his M.D., Ph.D., in 1982 and completed hisMedical Residency and Oncology Fellowship in 1985. He then worked for threeyears at the National Institutes of Health as a Medical Staff Fellow. Dr. Pardoll joined the departments ofoncology and medicine in 1988....
Source: Videocast - All Events - September 28, 2015 Category: Journals (General) Tags: Upcoming Events Source Type: video
1) Lentivector Gene Therapy for X-linked Severe Combined Immune Deficiency (XSCID) in Older Children, Young Adults with Impaired Immunity 2) A New Approach to Cancer Immunotherapy Targeting Unique Cancer Mutations
Lentivector Gene Therapy for X-linked Severe Combined Immune Deficiency (XSCID) in Older Children, Young Adults with Impaired Immunity and Recurrent Infections Despite Prior Haplo-transplant
Harry L. Malech, MD
Chief, Laboratory of Host Defenses and
Chief, Genetic Immunotherapy Section, NIAID
A New Approach to Cancer Immunotherapy Targeting Unique Cancer Mutations
Steven A. Rosenberg, MD, PhD
Chief, Surgery Branch, NCI
For more information go to http://www.cc.nih.gov/about/news/grcurrent.htmlAir date: 9/30/2015 12:00:00 PM (Source: Videocast - All Events)
Source: Videocast - All Events - September 1, 2015 Category: Journals (General) Tags: Upcoming Events Source Type: video
Cytokine Release Syndrome after T Cell Immunotherapy Meeting
Presented by: Office of the Director, NIHCategory: Recombinant DNA Advisory CommitteeAired date: 06/10/2015 (Source: Videocast - All Events)
Source: Videocast - All Events - June 12, 2015 Category: Journals (General) Tags: Past Events Source Type: video
Cancer Immunotherapy by Targeting Unique Cancer Mutations
Immunology Interest Group
Dr. Steve Rosenberg received his B.A. and M.D. degrees at Johns Hopkins University and a Ph.D. in Biophysics at Harvard University. After completing his residency training in surgery in 1974 at the Peter Bent Brigham Hospital in Boston, Massachusetts, Dr. Rosenberg became the Chief of Surgery at the NCI, NIH, a position he has held to the present time. Dr. Rosenberg has pioneered the development of effective immunotherapies and gene therapies for patients with advanced cancers. His studies of the adoptive transfer of genetically modified lymphocytes have resulted in the regression of metastatic c...
Source: Videocast - All Events - April 27, 2015 Category: Journals (General) Tags: Upcoming Events Source Type: video
